Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations33
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing23
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization23
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report22
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study20
Rapid point of care testing: the next frontier in pharmacogenomics20
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates19
KRAS-Targeted Therapies in Advanced Solid Cancers: Drug the Undruggable?19
A Meta-Analysis of Effects of Cyp2C9 and Cyp2C19 Polymorphisms on Phenytoin Pharmacokinetic Parameters18
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications17
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level15
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations15
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison15
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy14
0.038686037063599